Why is Medinova Diagno. falling/rising?

As of 09-Sep, Medinova Diagnostic Services Ltd is experiencing a slight decline in its stock price, currently at 42.40, reflecting a decrease of 0.1 or 0.24%. The stock has been losing value for the last two days, with a total decline of 1.17% during this period. Despite this recent downturn, the stock has shown strong performance over longer periods, with a 14.56% increase over the past year and a remarkable 200.28% rise over the last five years. However, the company faces challenges, including a negative book value and weak long-term fundamental strength, which may contribute to investor caution. In the broader market context, Medinova's recent performance has been in line with the sector, and it has outperformed the benchmark Sensex over various time frames, including a 4.31% gain over the past week compared to the Sensex's 1.18%. This indicates that while the stock has been performing well in the long term, its current decline may be influenced by its negative book value and high debt levels, which pose risks to its future growth. The rising investor participation, with a significant increase in delivery volume, suggests that there is still interest in the stock, but the overall sentiment may be tempered by the company's financial challenges.